A guide to the extrapyramidal side-effects of antipsychotic drugs:
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Cambridge
Cambridge University Press
2014
|
Ausgabe: | Second edition |
Schlagworte: | |
Online-Zugang: | TUM01 Volltext |
Beschreibung: | 1 Online-Ressource |
ISBN: | 9781139870788 1139870785 9781139149112 1139149113 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV042793144 | ||
003 | DE-604 | ||
005 | 20161229 | ||
007 | cr|uuu---uuuuu | ||
008 | 150902s2014 |||| o||u| ||||||eng d | ||
020 | |a 9781139870788 |c Online |9 978-1-139-87078-8 | ||
020 | |a 1139870785 |c Online |9 1-139-87078-5 | ||
020 | |a 9781139149112 |c Online |9 978-1-139-14911-2 | ||
020 | |a 1139149113 |c Online |9 1-139-14911-3 | ||
035 | |a (ZDB-4-NLEBK)696305 | ||
035 | |a (OCoLC)878078602 | ||
035 | |a (DE-599)BVBBV042793144 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-91 | ||
082 | 0 | |a 615.7/882 |2 23 | |
084 | |a XI 5820 |0 (DE-625)153018:12926 |2 rvk | ||
100 | 1 | |a Owens, David G. Cunningham |d 1949- |e Verfasser |0 (DE-588)13405900X |4 aut | |
245 | 1 | 0 | |a A guide to the extrapyramidal side-effects of antipsychotic drugs |c D.G. Cunningham-Owens |
250 | |a Second edition | ||
264 | 1 | |a Cambridge |b Cambridge University Press |c 2014 | |
300 | |a 1 Online-Ressource | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
505 | 8 | |a Includes bibliographical references and index | |
505 | 8 | |a Machine generated contents note: Preface; Part 1. Setting the Scene: 1. The origins of psychopharma; 2. Some preliminaries; Part 2. The Syndromes: 3. Acute dystonias; 4. Parkinsonism; 5. Akathisia; 6. Tardive dyskinesia; Part 3. Particular Issues: 7. Tardive and chronic dystonia; 8. Special populations; Part 4. Assessment: 9. The clinical examination; 10. An overview of some standardised recording instruments; Part 5. Matters Arising: 11. Involuntary movements and schizophrenia: a limitation to the concept of tardive dyskinesia?; 12. And finally ... the salutary tale of 'atypicality'; References; Index | |
505 | 8 | |a "It is often implied that antipsychotic-induced extrapyramidal side-effects are irrelevant to modern psychiatric therapeutics, rendered historic by newer, better treatments. This myth arises from limited awareness of the depth and breadth of neurological disruption antipsychotics can mediate. This volume discusses the extensive clinical boundaries of acute dystonias, drug-induced parkinsonism, akathisia and tardive dyskinesia, providing demographic and epidemiological context while illustrating how prescribing choices impact powerfully on their development. This new edition has been thoroughly updated and rewritten to include recent data, expanded references and a new chapter on the concept of 'atypical' antipsychotics. Written in a light, engaging style, liberally illustrated with clinical examples, it also invites readers to consider ongoing controversies - subjective drug effects, the relationship between 'akathisia' and restless legs, the status of the concept of 'atypicality', and so on. Informative reading for trainees as well as established practitioners in the fields of psychiatry, neurology, primary care and geriatrics"--Provided by publisher | |
650 | 4 | |a Basal Ganglia Diseases / chemically induced | |
650 | 4 | |a Antipsychotic Agents / adverse effects | |
650 | 4 | |a Extrapyramidal Tracts / drug effects | |
650 | 4 | |a Neurotoxicity Syndromes | |
650 | 7 | |a MEDICAL / Pharmacology |2 bisacsh | |
650 | 7 | |a Antipsychotic drugs / Side effects |2 fast | |
650 | 7 | |a Extrapyramidal disorders |2 fast | |
650 | 4 | |a Medizin | |
650 | 4 | |a Extrapyramidal disorders | |
650 | 4 | |a Antipsychotic drugs |x Side effects | |
650 | 0 | 7 | |a Psychopharmakon |0 (DE-588)4047729-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Nebenwirkung |0 (DE-588)4317914-9 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Psychopharmakon |0 (DE-588)4047729-0 |D s |
689 | 0 | 1 | |a Nebenwirkung |0 (DE-588)4317914-9 |D s |
689 | 0 | |5 DE-604 | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 978-1-107-02286-7 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 1-107-02286-X |
856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=696305 |x Aggregator |3 Volltext |
912 | |a ZDB-4-NLEBK | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-028222918 | ||
966 | e | |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=696305 |l TUM01 |p ZDB-4-NLEBK |q TUM_PDA_EBSCOMED_Kauf |x Aggregator |3 Volltext |
Datensatz im Suchindex
_version_ | 1804175027579387904 |
---|---|
any_adam_object | |
author | Owens, David G. Cunningham 1949- |
author_GND | (DE-588)13405900X |
author_facet | Owens, David G. Cunningham 1949- |
author_role | aut |
author_sort | Owens, David G. Cunningham 1949- |
author_variant | d g c o dgc dgco |
building | Verbundindex |
bvnumber | BV042793144 |
classification_rvk | XI 5820 |
collection | ZDB-4-NLEBK |
contents | Includes bibliographical references and index Machine generated contents note: Preface; Part 1. Setting the Scene: 1. The origins of psychopharma; 2. Some preliminaries; Part 2. The Syndromes: 3. Acute dystonias; 4. Parkinsonism; 5. Akathisia; 6. Tardive dyskinesia; Part 3. Particular Issues: 7. Tardive and chronic dystonia; 8. Special populations; Part 4. Assessment: 9. The clinical examination; 10. An overview of some standardised recording instruments; Part 5. Matters Arising: 11. Involuntary movements and schizophrenia: a limitation to the concept of tardive dyskinesia?; 12. And finally ... the salutary tale of 'atypicality'; References; Index "It is often implied that antipsychotic-induced extrapyramidal side-effects are irrelevant to modern psychiatric therapeutics, rendered historic by newer, better treatments. This myth arises from limited awareness of the depth and breadth of neurological disruption antipsychotics can mediate. This volume discusses the extensive clinical boundaries of acute dystonias, drug-induced parkinsonism, akathisia and tardive dyskinesia, providing demographic and epidemiological context while illustrating how prescribing choices impact powerfully on their development. This new edition has been thoroughly updated and rewritten to include recent data, expanded references and a new chapter on the concept of 'atypical' antipsychotics. Written in a light, engaging style, liberally illustrated with clinical examples, it also invites readers to consider ongoing controversies - subjective drug effects, the relationship between 'akathisia' and restless legs, the status of the concept of 'atypicality', and so on. Informative reading for trainees as well as established practitioners in the fields of psychiatry, neurology, primary care and geriatrics"--Provided by publisher |
ctrlnum | (ZDB-4-NLEBK)696305 (OCoLC)878078602 (DE-599)BVBBV042793144 |
dewey-full | 615.7/882 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615.7/882 |
dewey-search | 615.7/882 |
dewey-sort | 3615.7 3882 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
edition | Second edition |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04210nmm a2200613zc 4500</leader><controlfield tag="001">BV042793144</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20161229 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">150902s2014 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781139870788</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-139-87078-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1139870785</subfield><subfield code="c">Online</subfield><subfield code="9">1-139-87078-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781139149112</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-139-14911-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1139149113</subfield><subfield code="c">Online</subfield><subfield code="9">1-139-14911-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-4-NLEBK)696305</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)878078602</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV042793144</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-91</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.7/882</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 5820</subfield><subfield code="0">(DE-625)153018:12926</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Owens, David G. Cunningham</subfield><subfield code="d">1949-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)13405900X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">A guide to the extrapyramidal side-effects of antipsychotic drugs</subfield><subfield code="c">D.G. Cunningham-Owens</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">Second edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge</subfield><subfield code="b">Cambridge University Press</subfield><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Machine generated contents note: Preface; Part 1. Setting the Scene: 1. The origins of psychopharma; 2. Some preliminaries; Part 2. The Syndromes: 3. Acute dystonias; 4. Parkinsonism; 5. Akathisia; 6. Tardive dyskinesia; Part 3. Particular Issues: 7. Tardive and chronic dystonia; 8. Special populations; Part 4. Assessment: 9. The clinical examination; 10. An overview of some standardised recording instruments; Part 5. Matters Arising: 11. Involuntary movements and schizophrenia: a limitation to the concept of tardive dyskinesia?; 12. And finally ... the salutary tale of 'atypicality'; References; Index</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">"It is often implied that antipsychotic-induced extrapyramidal side-effects are irrelevant to modern psychiatric therapeutics, rendered historic by newer, better treatments. This myth arises from limited awareness of the depth and breadth of neurological disruption antipsychotics can mediate. This volume discusses the extensive clinical boundaries of acute dystonias, drug-induced parkinsonism, akathisia and tardive dyskinesia, providing demographic and epidemiological context while illustrating how prescribing choices impact powerfully on their development. This new edition has been thoroughly updated and rewritten to include recent data, expanded references and a new chapter on the concept of 'atypical' antipsychotics. Written in a light, engaging style, liberally illustrated with clinical examples, it also invites readers to consider ongoing controversies - subjective drug effects, the relationship between 'akathisia' and restless legs, the status of the concept of 'atypicality', and so on. Informative reading for trainees as well as established practitioners in the fields of psychiatry, neurology, primary care and geriatrics"--Provided by publisher</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Basal Ganglia Diseases / chemically induced</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antipsychotic Agents / adverse effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Extrapyramidal Tracts / drug effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurotoxicity Syndromes</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antipsychotic drugs / Side effects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Extrapyramidal disorders</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Extrapyramidal disorders</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antipsychotic drugs</subfield><subfield code="x">Side effects</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Psychopharmakon</subfield><subfield code="0">(DE-588)4047729-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Nebenwirkung</subfield><subfield code="0">(DE-588)4317914-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Psychopharmakon</subfield><subfield code="0">(DE-588)4047729-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Nebenwirkung</subfield><subfield code="0">(DE-588)4317914-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">978-1-107-02286-7</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">1-107-02286-X</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=696305</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-NLEBK</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028222918</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=696305</subfield><subfield code="l">TUM01</subfield><subfield code="p">ZDB-4-NLEBK</subfield><subfield code="q">TUM_PDA_EBSCOMED_Kauf</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV042793144 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T07:09:46Z |
institution | BVB |
isbn | 9781139870788 1139870785 9781139149112 1139149113 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028222918 |
oclc_num | 878078602 |
open_access_boolean | |
owner | DE-91 DE-BY-TUM |
owner_facet | DE-91 DE-BY-TUM |
physical | 1 Online-Ressource |
psigel | ZDB-4-NLEBK ZDB-4-NLEBK TUM_PDA_EBSCOMED_Kauf |
publishDate | 2014 |
publishDateSearch | 2014 |
publishDateSort | 2014 |
publisher | Cambridge University Press |
record_format | marc |
spelling | Owens, David G. Cunningham 1949- Verfasser (DE-588)13405900X aut A guide to the extrapyramidal side-effects of antipsychotic drugs D.G. Cunningham-Owens Second edition Cambridge Cambridge University Press 2014 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references and index Machine generated contents note: Preface; Part 1. Setting the Scene: 1. The origins of psychopharma; 2. Some preliminaries; Part 2. The Syndromes: 3. Acute dystonias; 4. Parkinsonism; 5. Akathisia; 6. Tardive dyskinesia; Part 3. Particular Issues: 7. Tardive and chronic dystonia; 8. Special populations; Part 4. Assessment: 9. The clinical examination; 10. An overview of some standardised recording instruments; Part 5. Matters Arising: 11. Involuntary movements and schizophrenia: a limitation to the concept of tardive dyskinesia?; 12. And finally ... the salutary tale of 'atypicality'; References; Index "It is often implied that antipsychotic-induced extrapyramidal side-effects are irrelevant to modern psychiatric therapeutics, rendered historic by newer, better treatments. This myth arises from limited awareness of the depth and breadth of neurological disruption antipsychotics can mediate. This volume discusses the extensive clinical boundaries of acute dystonias, drug-induced parkinsonism, akathisia and tardive dyskinesia, providing demographic and epidemiological context while illustrating how prescribing choices impact powerfully on their development. This new edition has been thoroughly updated and rewritten to include recent data, expanded references and a new chapter on the concept of 'atypical' antipsychotics. Written in a light, engaging style, liberally illustrated with clinical examples, it also invites readers to consider ongoing controversies - subjective drug effects, the relationship between 'akathisia' and restless legs, the status of the concept of 'atypicality', and so on. Informative reading for trainees as well as established practitioners in the fields of psychiatry, neurology, primary care and geriatrics"--Provided by publisher Basal Ganglia Diseases / chemically induced Antipsychotic Agents / adverse effects Extrapyramidal Tracts / drug effects Neurotoxicity Syndromes MEDICAL / Pharmacology bisacsh Antipsychotic drugs / Side effects fast Extrapyramidal disorders fast Medizin Extrapyramidal disorders Antipsychotic drugs Side effects Psychopharmakon (DE-588)4047729-0 gnd rswk-swf Nebenwirkung (DE-588)4317914-9 gnd rswk-swf Psychopharmakon (DE-588)4047729-0 s Nebenwirkung (DE-588)4317914-9 s DE-604 Erscheint auch als Druck-Ausgabe, Hardcover 978-1-107-02286-7 Erscheint auch als Druck-Ausgabe, Hardcover 1-107-02286-X http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=696305 Aggregator Volltext |
spellingShingle | Owens, David G. Cunningham 1949- A guide to the extrapyramidal side-effects of antipsychotic drugs Includes bibliographical references and index Machine generated contents note: Preface; Part 1. Setting the Scene: 1. The origins of psychopharma; 2. Some preliminaries; Part 2. The Syndromes: 3. Acute dystonias; 4. Parkinsonism; 5. Akathisia; 6. Tardive dyskinesia; Part 3. Particular Issues: 7. Tardive and chronic dystonia; 8. Special populations; Part 4. Assessment: 9. The clinical examination; 10. An overview of some standardised recording instruments; Part 5. Matters Arising: 11. Involuntary movements and schizophrenia: a limitation to the concept of tardive dyskinesia?; 12. And finally ... the salutary tale of 'atypicality'; References; Index "It is often implied that antipsychotic-induced extrapyramidal side-effects are irrelevant to modern psychiatric therapeutics, rendered historic by newer, better treatments. This myth arises from limited awareness of the depth and breadth of neurological disruption antipsychotics can mediate. This volume discusses the extensive clinical boundaries of acute dystonias, drug-induced parkinsonism, akathisia and tardive dyskinesia, providing demographic and epidemiological context while illustrating how prescribing choices impact powerfully on their development. This new edition has been thoroughly updated and rewritten to include recent data, expanded references and a new chapter on the concept of 'atypical' antipsychotics. Written in a light, engaging style, liberally illustrated with clinical examples, it also invites readers to consider ongoing controversies - subjective drug effects, the relationship between 'akathisia' and restless legs, the status of the concept of 'atypicality', and so on. Informative reading for trainees as well as established practitioners in the fields of psychiatry, neurology, primary care and geriatrics"--Provided by publisher Basal Ganglia Diseases / chemically induced Antipsychotic Agents / adverse effects Extrapyramidal Tracts / drug effects Neurotoxicity Syndromes MEDICAL / Pharmacology bisacsh Antipsychotic drugs / Side effects fast Extrapyramidal disorders fast Medizin Extrapyramidal disorders Antipsychotic drugs Side effects Psychopharmakon (DE-588)4047729-0 gnd Nebenwirkung (DE-588)4317914-9 gnd |
subject_GND | (DE-588)4047729-0 (DE-588)4317914-9 |
title | A guide to the extrapyramidal side-effects of antipsychotic drugs |
title_auth | A guide to the extrapyramidal side-effects of antipsychotic drugs |
title_exact_search | A guide to the extrapyramidal side-effects of antipsychotic drugs |
title_full | A guide to the extrapyramidal side-effects of antipsychotic drugs D.G. Cunningham-Owens |
title_fullStr | A guide to the extrapyramidal side-effects of antipsychotic drugs D.G. Cunningham-Owens |
title_full_unstemmed | A guide to the extrapyramidal side-effects of antipsychotic drugs D.G. Cunningham-Owens |
title_short | A guide to the extrapyramidal side-effects of antipsychotic drugs |
title_sort | a guide to the extrapyramidal side effects of antipsychotic drugs |
topic | Basal Ganglia Diseases / chemically induced Antipsychotic Agents / adverse effects Extrapyramidal Tracts / drug effects Neurotoxicity Syndromes MEDICAL / Pharmacology bisacsh Antipsychotic drugs / Side effects fast Extrapyramidal disorders fast Medizin Extrapyramidal disorders Antipsychotic drugs Side effects Psychopharmakon (DE-588)4047729-0 gnd Nebenwirkung (DE-588)4317914-9 gnd |
topic_facet | Basal Ganglia Diseases / chemically induced Antipsychotic Agents / adverse effects Extrapyramidal Tracts / drug effects Neurotoxicity Syndromes MEDICAL / Pharmacology Antipsychotic drugs / Side effects Extrapyramidal disorders Medizin Antipsychotic drugs Side effects Psychopharmakon Nebenwirkung |
url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=696305 |
work_keys_str_mv | AT owensdavidgcunningham aguidetotheextrapyramidalsideeffectsofantipsychoticdrugs |